Published in J Am Coll Surg on August 01, 2002
Sentinel Lymph Node Detection Using Carbon Nanoparticles in Patients with Early Breast Cancer. PLoS One (2015) 0.86
The inextricable axis of targeted diagnostic imaging and therapy: An immunological natural history approach. Nucl Med Biol (2015) 0.76
Sentinel lymph node biopsy for patients with breast cancer: five-year experience. Perm J (2005) 0.75
Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. J Clin Oncol (2007) 7.00
Esophageal sphincter device for gastroesophageal reflux disease. N Engl J Med (2013) 5.41
Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study. J Clin Oncol (2006) 3.53
Mammography before diagnosis among women age 80 years and older with breast cancer. J Clin Oncol (2008) 3.49
Oncologic safety of skin-sparing mastectomy. Ann Surg Oncol (2003) 3.32
Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor. Ann Surg Oncol (2006) 2.84
Breast cancer on the world wide web: cross sectional survey of quality of information and popularity of websites. BMJ (2002) 2.53
Long-term complications associated with breast-conservation surgery and radiotherapy. Ann Surg Oncol (2002) 2.51
Career satisfaction, practice patterns and burnout among surgical oncologists: report on the quality of life of members of the Society of Surgical Oncology. Ann Surg Oncol (2007) 2.50
Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy. Cancer (2003) 2.29
Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy. Ann Surg Oncol (2006) 2.23
Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma. Cancer (2002) 2.21
Changes in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage-specific survival. J Clin Oncol (2003) 2.19
Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy. J Clin Oncol (2005) 2.07
Standard for breast conservation therapy in the management of invasive breast carcinoma. CA Cancer J Clin (2002) 2.07
Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience. J Clin Oncol (2004) 2.00
Should surgical recertification reflect subspecialization? Am J Surg (2008) 1.93
Role for intraoperative margin assessment in patients undergoing breast-conserving surgery. Ann Surg Oncol (2007) 1.92
Long-term outcomes of an endoscopic myotomy for achalasia: the POEM procedure. Ann Surg (2012) 1.90
Surgical decision making and factors determining a diagnosis of breast carcinoma in women presenting with nipple discharge. J Am Coll Surg (2003) 1.81
Prognostic factors in node-negative breast cancer: a review of studies with sample size more than 200 and follow-up more than 5 years. Ann Surg (2002) 1.79
Impact of clinicopathological factors on sensitivity of axillary ultrasonography in the detection of axillary nodal metastases in patients with breast cancer. Ann Surg Oncol (2003) 1.74
A comparative study on comprehensive, objective outcomes of laparoscopic Heller myotomy with per-oral endoscopic myotomy (POEM) for achalasia. Ann Surg (2014) 1.72
Timing of surgical intervention for the intact primary in stage IV breast cancer patients. Ann Surg Oncol (2008) 1.71
Clinical biology and surgical therapy of intramucosal adenocarcinoma of the esophagus. J Am Coll Surg (2006) 1.71
Treatment and outcome of patients with intracystic papillary carcinoma of the breast. Am J Surg (2002) 1.70
Trends for inflammatory breast cancer: is survival improving? Oncologist (2007) 1.70
Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy. Ann Surg (2006) 1.70
Anaphylactoid reactions to isosulfan blue dye during breast cancer lymphatic mapping in patients given preoperative prophylaxis. J Clin Oncol (2004) 1.61
Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg (2005) 1.61
A stepwise approach and early clinical experience in peroral endoscopic myotomy for the treatment of achalasia and esophageal motility disorders. J Am Coll Surg (2011) 1.55
Metastases to the breast from nonbreast solid neoplasms: presentation and determinants of survival. Cancer (2007) 1.54
Effective local control and long-term survival in patients with T4 locally advanced breast cancer treated with breast conservation therapy. Ann Surg Oncol (2004) 1.52
Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy. Int J Radiat Oncol Biol Phys (2002) 1.51
T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy. Int J Radiat Oncol Biol Phys (2004) 1.51
Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry. Cancer (2005) 1.50
Peroral endoscopic esophageal myotomy: defining the learning curve. Gastrointest Endosc (2013) 1.46
Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol (2003) 1.45
Esophagectomies with thoracic incisions carry increased pulmonary morbidity. JAMA Surg (2013) 1.45
Long-term survival after an aggressive surgical approach in patients with breast cancer hepatic metastases. Ann Surg Oncol (2004) 1.45
A triangulating operating platform enhances bimanual performance and reduces surgical workload in single-incision laparoscopy. J Am Coll Surg (2010) 1.44
Breast cancer in reduction mammaplasty specimens: case reports and guidelines. Breast J (2003) 1.41
Incidence and time course of bleeding after long-term amenorrhea after breast cancer treatment: a prospective study. Cancer (2010) 1.39
Future applications of flexible endoscopy in esophageal surgery. J Gastrointest Surg (2009) 1.37
A prospective trial of preoperative chemotherapy in resectable breast cancer: predictors of breast-conservation therapy feasibility. Ann Surg Oncol (2002) 1.33
Intraoperative margin assessment reduces reexcision rates in patients with ductal carcinoma in situ treated with breast-conserving surgery. Am J Surg (2003) 1.33
Standard for the management of ductal carcinoma in situ of the breast (DCIS). CA Cancer J Clin (2002) 1.32
Small (< or = 2-cm) breast cancer treated with US-guided radiofrequency ablation: feasibility study. Radiology (2004) 1.29
Multidisciplinary management of breast cancer concurrent with pregnancy. J Am Coll Surg (2002) 1.25
Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation. J Clin Oncol (2002) 1.20
Peroral endoscopic myotomy (POEM) is safe and effective in the setting of prior endoscopic intervention. J Gastrointest Surg (2013) 1.20
The effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancer. Cancer (2004) 1.18
Intramammary lymph node metastases are an independent predictor of poor outcome in patients with breast carcinoma. Cancer (2004) 1.18
Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients. Carcinogenesis (2004) 1.17
Contralateral prophylactic mastectomy. Predictors of significant histologic findings. Cancer (2004) 1.16
Laparoscopic ventral hernia repair: are there comparative advantages over traditional methods of repair? Am Surg (2002) 1.15
Intraoperative assessment of esophagogastric junction distensibility during per oral endoscopic myotomy (POEM) for esophageal motility disorders. Surg Endosc (2012) 1.15
Locoregional treatment outcomes after multimodality management of inflammatory breast cancer. Int J Radiat Oncol Biol Phys (2008) 1.15
The nuclear transcription factor kappaB/bcl-2 pathway correlates with pathologic complete response to doxorubicin-based neoadjuvant chemotherapy in human breast cancer. Clin Cancer Res (2005) 1.12
Breast cancer recurrence after immediate reconstruction: patterns and significance. Plast Reconstr Surg (2003) 1.09
Chest wall recurrence after mastectomy does not always portend a dismal outcome. Ann Surg Oncol (2003) 1.08
Improving local control with breast-conserving therapy: a 27-year single-institution experience. Cancer (2005) 1.08
An open-label study to evaluate the safety and efficacy of tissue plasminogen activator in treatment of severe frostbite. J Trauma (2005) 1.07
Peroral endoscopic myotomy (POEM) for esophageal primary motility disorders: analysis of 100 consecutive patients. J Gastrointest Surg (2014) 1.04
Breast conservation after neoadjuvant chemotherapy. Cancer (2005) 1.04
Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situ. Cancer (2004) 1.03
Laparoscopic and endoscopic pyloroplasty for gastroparesis results in sustained symptom improvement. J Gastrointest Surg (2011) 1.03
Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy. Ann Surg Oncol (2002) 1.02
Evaluation of paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: preliminary data of a prospective randomized trial. Clin Cancer Res (2002) 1.01
Surgical time independently affected by surgical team size. Am J Surg (2009) 1.00
Polymorphisms and haplotypes of the NBS1 gene are associated with risk of sporadic breast cancer in non-Hispanic white women <or=55 years. Carcinogenesis (2006) 1.00
Outcomes of Nissen fundoplication in patients with gastroesophageal reflux disease and delayed gastric emptying. Arch Surg (2009) 0.97
Nipple aspirate fluid cytology in breast carcinoma. Cancer (2003) 0.97
Predictors of systemic recurrence and disease-specific survival after ipsilateral breast tumor recurrence. Cancer (2005) 0.96
Accuracy of the combination of mammography and sonography in predicting tumor response in breast cancer patients after neoadjuvant chemotherapy. Ann Surg Oncol (2006) 0.95
Paget's disease of the breast: there is a role for breast-conserving therapy. Ann Surg Oncol (2005) 0.95
Bimanual coordination in natural orifice transluminal endoscopic surgery: comparing the conventional dual-channel endoscope, the R-Scope, and a novel direct-drive system. Gastrointest Endosc (2009) 0.94
Breast cancer vaccines: promise for the future or pipe dream? Cancer (2007) 0.93
High and differential expression of HER-2/neu extracellular domain in bilateral ductal fluids from women with unilateral invasive breast cancer. Clin Cancer Res (2003) 0.93
Epidermal growth factor receptor expression correlates with poor survival in patients who have breast carcinoma treated with doxorubicin-based neoadjuvant chemotherapy. Cancer (2005) 0.92
Locoregional treatment outcomes for inoperable anthracycline-resistant breast cancer. Int J Radiat Oncol Biol Phys (2002) 0.92
Effect of dietary intake of phytoestrogens on estrogen receptor status in premenopausal women with breast cancer. Nutr Cancer (2005) 0.89
Current comprehensive assessment and management of women at increased risk for breast cancer. Am J Surg (2004) 0.89
Treatment and outcome of patients with chest wall recurrence after mastectomy and breast reconstruction. Am J Surg (2004) 0.89
Expressive writing as a presurgical stress management intervention for breast cancer patients. J Soc Integr Oncol (2008) 0.87
Patient factors predictive of 24-h pH normalization following endoluminal gastroplication for GERD. Surg Endosc (2009) 0.87
Implications of axillary sentinel lymph node biopsy in immediate autologous breast reconstruction. Plast Reconstr Surg (2002) 0.87
The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapy. Cancer (2006) 0.87
Incidence and prevention of venous thromboembolism in patients undergoing breast cancer surgery and treated according to clinical pathways. Ann Surg (2006) 0.87
Thymidylate synthase polymorphisms and mRNA expression are independent chemotherapy predictive markers in esophageal adenocarcinoma patients. Int J Oncol (2008) 0.87
End of the road for a dysfunctional end organ: laparoscopic gastrectomy for refractory gastroparesis. J Gastrointest Surg (2015) 0.87
The impact of reflux composition on mucosal injury and esophageal function. J Gastrointest Surg (2006) 0.86
Changes in female support network systems and adaptation after breast cancer diagnosis: differences between older and younger patients. Gerontologist (2009) 0.85
A randomized multiinstitution comparison of the laparoscopic Nissen and Hill repairs. Ann Thorac Surg (2012) 0.84
Paraesophageal hernia repair with biomesh does not increase postoperative dysphagia. J Gastrointest Surg (2011) 0.84
Overview of adjuvant systemic therapy in early stage breast cancer. Surg Clin North Am (2007) 0.84
Video: natural orifice translumenal endoscopic surgery (NOTES): creation of a gastric valve for safe and effective transgastric surgery in humans. Surg Endosc (2009) 0.84